Form 4 for BNGO Bionano Genomics, Inc.
Accepted 2023-05-16 00:00:00 ET · period of report 2023-05-16 · accession 0001411690-23-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-16 | 2023-05-16 | BNGO | Holmlin R. Erik | Pres, CEO, Dir | P - Purchase | $0.64 | +15.0K | 806.5K | +2% | +$9,600 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-16 | P | A | 15,000 | $0.64 | 806,474 | D | — | — | (F1) The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.64160 to $0.643099, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. |